Bicara Therapeutics Inc. Income Taxes Paid
Bicara Therapeutics Inc. (BCAX) reported Income Taxes Paid of $155.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow
us-gaap:IncomeTaxesPaid · last filed 2026-08-11
- Bicara Therapeutics Inc. income taxes paid for the quarter ending 2026-06-30 was $155.00K, a 198.08% increase year-over-year.
- Bicara Therapeutics Inc. income taxes paid for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Bicara Therapeutics Inc. income taxes paid for the quarter ending 2025-09-30 was $167.00K.
- Bicara Therapeutics Inc. income taxes paid for the quarter ending 2025-06-30 was $52.00K.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month |
|---|---|---|---|
| 2026-06-30 | $155.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $155.00K 10-Q · filed 2026-08-11 | |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 | ||
| 2025-09-30 | $167.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $219.00K derived: sum of 2 quarters · filed 2026-08-11 | $291.00K 10-Q · filed 2025-11-10 |
| 2025-06-30 | $52.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $124.00K 10-Q · filed 2026-08-11 | |
| 2025-03-31 | $72.00K 10-Q · filed 2026-05-11 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2025-11-10 | $1.00K 10-Q · filed 2025-11-10 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $1.00K 10-Q · filed 2025-08-12 | |
| 2024-03-31 | $1.00K 10-Q · filed 2025-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Kardigan, Inc. (KARD) | United States | $1.346B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B |